2/9
09:42 am
evh
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion [Yahoo! Finance]
Low
Report
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion [Yahoo! Finance]
2/4
11:02 am
evh
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
Low
Report
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
2/2
01:46 pm
evh
MedeAnalytics Appoints Chris Lance as Chief Product Officer [Yahoo! Finance]
Low
Report
MedeAnalytics Appoints Chris Lance as Chief Product Officer [Yahoo! Finance]
2/2
08:04 am
evh
Evolent Health (NYSE:EVH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock, down previously from $16.00.
Low
Report
Evolent Health (NYSE:EVH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock, down previously from $16.00.
1/9
10:58 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.
1/6
08:02 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $11.00 to $10.00. They now have a "market outperform" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $11.00 to $10.00. They now have a "market outperform" rating on the stock.
1/6
07:07 am
evh
Evolent Health (NYSE:EVH) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Evolent Health (NYSE:EVH) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
1/2
04:15 pm
evh
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
Low
Report
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
12/2
03:00 pm
evh
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.
Low
Report
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.
11/26
02:06 pm
evh
Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
03:23 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.
11/20
01:47 am
evh
Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]
Low
Report
Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]
11/17
12:37 pm
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.
Medium
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.
11/14
03:26 pm
evh
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves [Seeking Alpha]
Low
Report
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves [Seeking Alpha]